Breaking News
September 25, 2018 - Study explores link between genetic predisposition to Alzheimer’s and cardiometabolic risk factors
September 25, 2018 - NeoTract presents new clinical data from studies of UroLift System for patients with BPH
September 25, 2018 - Statins Improve Long-Term Survival After AAA Repair
September 25, 2018 - Novel brain network linked to chronic pain in Parkinson’s disease
September 25, 2018 - Researchers reassess negative pressure wound therapy as its benefit and harm remain unclear
September 25, 2018 - Older adults with ‘fall plan of care’ less likely to suffer fall-related hospitalizations
September 25, 2018 - FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials
September 25, 2018 - IME Medical Electrospinning establishes state-of-the-art manufacturing lab facilities
September 25, 2018 - Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results
September 25, 2018 - How to Protect Your Eyesight
September 25, 2018 - Novel approach allows researchers to define how cells in the retina respond to diabetes
September 25, 2018 - Columbia University announces winners of 2018 Louisa Gross Horwitz Prize
September 25, 2018 - Clinical trial investigators found non-compliant with requirement to report results on EU register
September 25, 2018 - U.S. Alzheimer’s Cases to Nearly Triple by 2060
September 25, 2018 - Improving cell replacement therapy for Parkinson’s disease
September 25, 2018 - Genervon reports new findings that drug candidate GM6 attenuates Alzheimer’s disease in mice model
September 25, 2018 - FDA approves new 5 mm diameter drug-eluting stent from Cook Medical
September 25, 2018 - New $17.8 million grant ensures USC at forefront of research on tobacco-related health risks
September 25, 2018 - Researchers analyze response to combination immunotherapy for patients with rare skin cancer
September 25, 2018 - Study sheds light on how brain protein may be involved neurodevelopmental disorders
September 25, 2018 - Where to draw the line on incentives
September 25, 2018 - Solid fuel use linked with increased risk of hospitalization or death from respiratory diseases
September 25, 2018 - ‘Trouble Brewing’ report highlights steps that governments can take to reduce alcohol-related harms
September 25, 2018 - Recurrence risk of VTE appears similar for patients with cancer and those with unprovoked VTE
September 25, 2018 - Global leaders must make bold commitments at first-ever UN tuberculosis summit
September 25, 2018 - Brief sleep intervention works long-term to prevent child obesity
September 25, 2018 - Vaping among kids and teens a growing concern
September 25, 2018 - Public launch of products and application solutions from Porvair Laboratory Division
September 25, 2018 - Harmful H. pylori may play a role in Parkinson’s disease
September 25, 2018 - Researchers develop way to measure different types of fear of falling in patients with Parkinson’s
September 25, 2018 - Fracture causes bone density losses throughout the body
September 25, 2018 - Researchers highlight potential therapy for treating rare, deadly blood-clotting disorder
September 25, 2018 - Hybrid theranostic complex shows high therapeutic efficacy against tumor cells
September 25, 2018 - FDA Issues Statement Reaffirming the Positive Benefit-Risk Profile of Nuplazid (pimavanserin) for Patients with Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis
September 25, 2018 - Toxicological evaluation and dosimetry estimation of potential PET radiotracer
September 25, 2018 - 5 obstacles parents commonly face in child obesity treatment and how to overcome them
September 25, 2018 - Immunologist to study how Chikungunya causes devastating effects in older adults
September 25, 2018 - Rural borderland communities vulnerable to high stress impacting mental and physical health
September 25, 2018 - SNMMI announces recipients of 2018-2020 Wagner-Torizuka Fellowship
September 25, 2018 - Common painkiller not effective in controlling chronic pain after traumatic nerve injury
September 25, 2018 - New therapeutic vaccine helps immune cells fight HPV-related head and neck cancer
September 25, 2018 - Environmentally-induced gene activity influences IQ test performance
September 25, 2018 - Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI
September 25, 2018 - FDA Approves Copiktra (duvelisib) Capsules for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma
September 25, 2018 - Medical device company settles US case over false claims
September 25, 2018 - Trying to get answers: One woman’s quest for a diagnosis
September 25, 2018 - Lung cancer patients treated with invasive surgery more likely to become chronic opioid users
September 25, 2018 - Oxford VR raises £3.2m to boost innovation in VR for mental health problems
September 25, 2018 - Gene therapy approach could help treat mitochondrial diseases
September 25, 2018 - Few Yogurt Products Qualify As Low-Sugar
September 25, 2018 - Eye disease can cause blindness, and it’s on the rise
September 25, 2018 - Pawnshop density linked to gun-related suicides, Stanford study finds
September 25, 2018 - Pioneering procedure for common prostate condition offered by The London Clinic
September 25, 2018 - Number of people with respiratory diseases likely to increase if UK air pollution remains unchecked
September 25, 2018 - FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial
September 25, 2018 - New program to reduce harmful stress effectively improves mood in cancer patients
September 24, 2018 - Florence’s Lingering Threat: Mold – Drugs.com MedNews
September 24, 2018 - For professional baseball players, faster hand-eye coordination linked to batting performance
September 24, 2018 - Bill for later school start times is defeated, but Stanford sleep specialist isn’t
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Successful recovery from addiction means more than achieving abstinence
September 24, 2018 - New nanoplatform technology may reverse drug-resistance in renal cell carcinoma
September 24, 2018 - October 1918 marks the centenary of Spanish Flu that claimed more lives than World War I
September 24, 2018 - LGBT community reports more number of poor mental health days than general population
September 24, 2018 - New research suggests power of zebrafish as tool for cancer drug discovery
September 24, 2018 - New study finds height as possible risk factor for developing varicose veins
September 24, 2018 - Researchers compare weight loss results of online and in-person diabetes prevention program
September 24, 2018 - New HER2 PET Study Uses Affibody’s ABY-025 Tracer to Individualize Breast Cancer Treatment
September 24, 2018 - Drug combination offers more effective care for patients suffering miscarriage
September 24, 2018 - Tallness linked to varicose veins, Stanford study says
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Ecstasy drug makes octopuses more social
September 24, 2018 - Immediate compression therapy could cut risk of complications after deep-vein thrombosis
September 24, 2018 - Transcatheter mitral valve repair reduces mortality for patients with mitral regurgitation
September 24, 2018 - First intracranial aneurysm patients treated with BRAVO Flow Diverter after CE mark approval
September 24, 2018 - ‘Physicians of the mouth’? Dentists absorb the medical billing drill
September 24, 2018 - People more likely to believe those with confident tone of voice than with accent
September 24, 2018 - Harmony Biosciences Presents 5-Year Data On Pitolisant At International Narcolepsy Symposium
September 24, 2018 - Blood test may identify gestational diabetes risk in first trimester
September 24, 2018 - Height may be risk factor for varicose veins | News Center
Facial Scarring Improved with Botulinum Toxin

Facial Scarring Improved with Botulinum Toxin

image_pdfDownload PDFimage_print

Action Points

  • Note that this small randomized trial suggested that botulinum toxin may be superior to placebo for reducing certain scar characteristics after a laceration closure.
  • Be aware that the primary outcome, score on the Vancouver Scar Scale, was not significantly different between the two groups, but this may be due to the small sample size for comparison.

Intradermal injection of botulinum toxin type A (Botox) immediately following wound closure improved the appearance of facial surgical scars compared with control scars in a small, randomized, double-blind trial from the People’s Republic of China.

At 6 months’ follow-up, the half of each facial scar treated with the injections following wound closure was narrower and flatter than the half left untreated, Li Hu, MD, PhD, and colleagues from the Shanghai Jiao Tong University School of Medicine Shanghai, reported in Plastic and Reconstructive Surgery.

The mean Vancouver Scar Scale score, used to characterize hypertrophic scars, was also lower for the half of the scar that was treated with the toxin, at 4.68 compared with 5.24 for the half that was not treated, although this difference was not statistically significant (P=0.146), the investigators added.

“Too many reports have focused on the treatment rather than the prevention of untoward surgical scars. However, early management of surgical scars is more likely to yield a better cosmetic appearance and require fewer treatments. This study demonstrates that early postsurgical botulinum toxin injections can produce better, narrower, and flatter facial surgical scars [than scars that remain untreated].”

For the study, 16 patients were randomized to receive botulinum toxin type A injections to half of their facial scar and the other half of the scar was treated with 0.9% normal saline.

“Immediately after skin closure, the encoded vial contents (0.2 mL containing 10 U for each 1-cm scar) were injected at a distance of 5 mm on either side of the wound,” the team wrote. The mean amount of botulinum toxin injected per scar was 33.7 U (range, 15 to 80 U). The mean age of the subjects was 12 (range, 6 to 49), while the mean length of the scar was 6.74 cm (range, 3 to 16 cm). The original diagnoses included congenital melanocytic nevi, port-wine stains, arteriovenous malformations, and disfiguring scars. Fourteen of the 16 patients completed the study.

In a subset analysis, the difference in the Vancouver Scar Scale height score at 6 months was significantly lower, at 0.47 for the treated part of the scar compared with 0.76 for the half that was not treated (P=0.009). At the same time point, the treated portion of the scar was also significantly narrower at 0.32, compared with 0.43 (P=0.001) for the untreated segment of the scar. The mean visual analogue scale (VAS) score was also higher at 5.76 for the treated part of the scar, compared with 4.97 for the control side — a difference between the two sides that was again significant (P=0.046).

In contrast, no significant differences were seen in the subdomains of pigmentation at 1.63 for the treated side versus 1.58 for the control side (P=0.391) or in vascularity, at 1.24 for the treated side versus 1.32 for the control side (P=0.263). No adverse events were noted. Tension at the edges of a wound significantly contributes to unsightly scars, the researchers explained.

“Temporary muscular paralysis induced by botulinum toxin type A could decrease movement and stress around a healing wound. This relief of tension may help prevent facial scar widening, hypertrophy, and hyperpigmentation.”

The authors also noted that botulinum toxin may have a direct inhibitory effect on fibroblasts and transforming growth factor-β1 expression, both key to the development of hypertrophic scars. A previously published study similarly found that early injections of the same botulinum toxin improved the appearance of facial scars — again by inducing temporary muscle paralysis and decreasing tension on wound edges.

Asked for her opinion, Tina Alster, MD, director of the Washington Institute of Dermatologic Laser Surgery in Washington, D.C., who was not involved with the study, pointed out that one of the limitations was the small sample size. She also noted that in general, scars on the face and neck tend to heal fairly well, as they are not under a lot of tension, which can contribute to unsightly scars.

However, she said she agreed in principle that starting early to try and minimize scars is a good idea: “I do a lot of laser scar revision and even using lasers to reverse red or hypertrophic keloid scars, we found that the earlier you start using the laser, the less severe the scar, and the earlier the scar looks better.”

In addition, Alster said, for many practitioners, incorporating the use of botulinum toxin into the practice of scar management is likely to be more readily available than the use of lasers, although in her own practice, she has found it actually to be less expensive and even less invasive to use a laser for scar revision than to inject botulinum toxin around a wound.

“I think it’s an important study if only because it asks the question, will the use of Botox or any of the other neuromodulators reduce scar formation by directly reducing the mechanical forces across a wound bed, and that answer is likely yes.”

“So in general this is a ‘thumbs up’ study, but with the caveat that larger studies of more significant scars are still warranted.”

The study authors, as well as Alster, reported having no financial conflicts of interest.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2018-03-13T12:00:00-0400

Tagged with:

About author

Related Articles